Payers and providers play an important role in addressing the opioid crisis in our communities. This page highlights the most recently added resources specifically targeting healthcare providers, healthcare system employees, and individuals who manage private and public insurance plans. These resources, identified with blue tiles, include patient and provider education materials, clinical practice guidelines and practice protocols, and research and reports about insurance coverage and benefit design around addiction treatment and pain management.
If you’d like to submit materials for inclusion consideration or suggest a future featured topic, please visit CLOUD’s call for submissions page.
The 2018 Arizona guidelines for the treatment of acute and chronic pain are intended to reduce over-reliance on opioid therapy in treating chronic pain and increase awareness of the risks of opioid therapy. It includes 17 guidelines addressing treatment of acute and chronic pain, and opioid
Arizona’s Department of Health Services provided these frequently asked questions about the opioid reporting requirements of the state.
Deans and curriculum representatives from all 18 schools educating health care providers in Arizona came together to develop a new curriculum on pain and addiction. The curriculum seeks to “redefine pain and addiction as multidimensional, interrelated public health issues that require the
Deans and curriculum representatives from all 18 schools educating health care providers in Arizona came together to develop a new curriculum on pain and addiction. The curriculum seeks to “redefine pain and addiction as multidimensional, interrelated public health issues that require the
The Arizona Department of Health Services created this frequently asked questions resource to explain the state’s opioid prescribing and opioid treatment rules.
The Arizona Department of Health Services created these frequently asked questions to explain the state requirement that pharmacists report naloxone doses dispensed to the state.
The Arizona Department of Health Services created these frequently asked questions to explain the state requirement that health care providers report cases of neonatal opioid withdrawal (or neonatal abstinence syndrome) as part of the state’s enhanced opioid surveillance.
The Arizona Department of Health Services created these frequently asked questions about the state’s naloxone distribution program and the requirement that health care providers and first responders report naloxone dispensing and administration.
As part of Arizona’s enhanced opioid surveillance, the Arizona Department of Health Services laboratory tests blood samples collected from individuals with suspected opioid overdoses. The laboratory performs a qualitative analysis to detect standard narcotics, opioids, fentanyl
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This one page document lists the steps prescribers need to take to implement electronic prescribing in their practices.